These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26614033)

  • 1. Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma.
    Krabbe LM; Margulis V; Lotan Y
    Urol Clin North Am; 2016 Feb; 43(1):105-18. PubMed ID: 26614033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of cell cycle and proliferative biomarkers in patients with clear cell renal cell carcinoma.
    Gayed BA; Youssef RF; Bagrodia A; Kapur P; Darwish OM; Krabbe LM; Sagalowsky A; Lotan Y; Margulis V
    J Urol; 2013 Nov; 190(5):1662-7. PubMed ID: 23792148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
    Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients.
    Yang X; Xi C; Jin J; Zhou L; Su J; Liu L; Liu Y
    Ann Diagn Pathol; 2015 Apr; 19(2):57-63. PubMed ID: 25708024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and immunohistochemical characteristics of papillary renal cell carcinoma with emphasis on subtyping.
    Alomari AK; Nettey OS; Singh D; Kluger H; Adeniran AJ
    Hum Pathol; 2015 Oct; 46(10):1418-26. PubMed ID: 26239624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
    Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
    Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype.
    Delahunt B; Bethwaite PB; Nacey JN
    Pathology; 2007 Oct; 39(5):459-65. PubMed ID: 17886093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma.
    Martignoni G; Brunelli M; Gobbo S; Remo A; Ficarra V; Cossu-Rocca P; Pea M; Chilosi M; Menestrina F; Cheng L
    Anal Quant Cytol Histol; 2007 Feb; 29(1):41-9. PubMed ID: 17375873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
    Migita T; Oda Y; Naito S; Tsuneyoshi M
    Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xp11 translocation renal cell carcinoma morphologically mimicking clear cell-papillary renal cell carcinoma in an adult patient: report of a case expanding the morphologic spectrum of Xp11 translocation renal cell carcinomas.
    Parihar A; Tickoo SK; Kumar S; Arora VK
    Int J Surg Pathol; 2015 May; 23(3):234-7. PubMed ID: 25519951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
    Zhang Y; Li J; Song Y; Chen F; Pei Y; Yao F
    Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression of napsin A in renal neoplasms.
    Zhu B; Rohan SM; Lin X
    Diagn Pathol; 2015 Mar; 10():4. PubMed ID: 25889632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.
    Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Darwish OM; Haddad AQ; Khalil D; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    J Urol; 2014 Jun; 191(6):1671-7. PubMed ID: 24291548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.